Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251

Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251

Mucosal surfaces are a primary route of HIV entry, yet the compartmentalisation between mucosal and peripheral immune systems remain a challenge for HIV vaccine candidates. Authors utilise a combination of intranodal tonsil MALT and systemic vaccination in the rhesus macaque model to explore immune...

Full description

Bibliographic Details
Main Authors:	Jeffy G. Mattathil, Asisa Volz, Olusegun O. Onabajo, Sean Maynard, Sandra L. Bixler, Xiaoying X. Shen, Diego Vargas-Inchaustegui, Marjorie Robert-Guroff, Celia Lebranche, Georgia Tomaras, David Montefiori, Gerd Sutter, Joseph J. Mattapallil
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-03-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-36907-0

Similar Items

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge.
by: Iskra Tuero, et al.
Published: (2015-08-01)

Characterization in rabbits & nonhuman primates of the neutralizing antibody response elicited by DNA & protein vaccination with SIVmac251 & SIVsmE660
by: Menon VP, et al.
Published: (2012-09-01)

Intra-dermal immunisation with SIV gag-based vaccines alone inhibits acquisition of SIVmac251
by: Almond N, et al.
Published: (2012-09-01)

SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
by: Mortara Lorenzo, et al.
Published: (2006-08-01)

P03-11. DNA vaccination with IL-12 lowers viral replication following SIVmac251 challenge
by: Boyer JD, et al.
Published: (2009-10-01)

Repeated semen exposure decreases cervicovaginal SIVmac251 infection in rhesus macaques
by: Shaheed A. Abdulhaqq, et al.
Published: (2019-08-01)

DNA/long peptide vaccination against conserved regions of SIV induces partial protection against SIVmac251 challenge.
by: Koopman, G, et al.
Published: (2013)

Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.
by: Giacomo Gorini, et al.
Published: (2020-03-01)

Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy
by: James B. Whitney, et al.
Published: (2018-12-01)

Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge.
by: Lauren A Hirao, et al.
Published: (2011-01-01)

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
by: Arwen F. Altenburg, et al.
Published: (2014-07-01)

Significant genetic heterogeneity of the SIVmac251 viral swarm derived from different sources.
by: Strickland, S, et al.
Published: (2011)

Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques
by: Mannioui Abdelkrim, et al.
Published: (2009-01-01)

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice
by: Svenja Veit, et al.
Published: (2018-12-01)

P19-49. Modulation of vaccine induced responses through CTLA-4 and 41BB enhances protection in macaques following SIVmac251 challenge
by: Jure-Kunkel MN, et al.
Published: (2009-10-01)

SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection.
by: Petrovas, C, et al.
Published: (2007)

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques
by: Mohammad Arif Rahman, et al.
Published: (2023-04-01)

Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors
by: Steven Tuyishime, et al.
Published: (2018-05-01)

Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques.
by: Lucas Gonzalez-Nieto, et al.
Published: (2019-09-01)

Activation of interferon regulatory factor 3 by replication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses
by: Stephanie Riederer, et al.
Published: (2021-09-01)

Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques
by: Celina M. Abreu, et al.
Published: (2019-08-01)

P20-13. Identification and characterization of early founder populations in Rhesus macaques vaginally infected with SIVmac251
by: Shaw GM, et al.
Published: (2009-10-01)

E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox
by: Asisa Volz, et al.
Published: (2018-01-01)

Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.
by: Konstantin Virnik, et al.
Published: (2020-01-01)

Efficient transmission and persistence of low-frequency SIVmac251 variants in CD8-depleted rhesus macaques with different neuropathology.
by: Strickland, S, et al.
Published: (2012)

Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge.
by: Arun K Sasikala-Appukuttan, et al.
Published: (2013-01-01)

Long-lasting Decrease in Viremia In Chronically SIVmac251-infected Macaques After Therapeutic Immunization With Combinations Of DNA Vectors
by: Pavlakis George N
Published: (2005-12-01)

Early divergent host responses in SHIVsf162P3 and SIVmac251 infected macaques correlate with control of viremia.
by: Huanbin Xu, et al.
Published: (2011-03-01)

Evaluation of Functional NK Cell Responses in Vaccinated and SIV-Infected Rhesus Macaques
by: Diego A. Vargas-Inchaustegui, et al.
Published: (2016-08-01)

The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice
by: Kim Thi Hoang Do, et al.
Published: (2023-10-01)

Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise
by: Mareike Kubinski, et al.
Published: (2020-08-01)

Preservation of a subset of SIV-specific central memory CD4+ T cells correlates with control of viremia in SIVmac251 infected macaques
by: Jalah Rashmi, et al.
Published: (2006-12-01)

Intranodal palisaded myofibroblastoma (intranodal hemorrhagic spindle cell tumor with amianthoid fibers): a case report and literature review
by: Karagülle Çetin, et al.
Published: (2010-02-01)

Efficacy of vaccine-induced Vif-specific CTL responses against SIVmac239 infection: implications for antigen design in AIDS vaccines
by: Iwamoto N, et al.
Published: (2012-09-01)

Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy
by: Takashi Morisaki, et al.
Published: (2022-05-01)

Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals
by: Earl Patricia, et al.
Published: (2005-02-01)

Oncolytic Vaccinia Virus in Lung Cancer Vaccines
by: Cao-Sang Truong, et al.
Published: (2022-02-01)

P14-08. Intramuscular DNA delivery by electroporation leads to greatly enhanced systemic and mucosal immune responses and control of SIVmac251 challenge
by: Khan A, et al.
Published: (2009-10-01)

Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure
by: Jeffy George, et al.
Published: (2018-02-01)

Clinical development of Modified Vaccinia virus Ankara vaccines
by: Gilbert, S
Published: (2013)